REGULATORY AFFAIRS DEPARTMENT

Company Profile: Regulatory Affairs Department (Malaysia)

Classification: Service Provider (Consultancy/Compliance Agency)

Business Nature: This department functions as a professional regulatory consultancy and compliance service provider rather than a physical manufacturing factory or a traditional goods trading company. It specializes in navigating the legal frameworks, quality standards, and registration requirements set by Malaysian authorities such as the National Pharmaceutical Regulatory Agency (NPRA) or the Ministry of Health (MOH).

Core Functions:

1. Product Registration: Managing the submission and approval process for pharmaceuticals, medical devices, cosmetics, and health supplements with local regulatory bodies.

2. Compliance Management: Ensuring that all imported or locally produced goods adhere to Malaysian safety, labeling, and quality standards.

3. Liaison Services: Acting as the official representative or communication bridge between international manufacturers and Malaysian government agencies.

4. Quality Assurance Consulting: Advising clients on Good Manufacturing Practice (GMP) requirements and documentation necessary for market entry in Malaysia.

Summary: The Regulatory Affairs Department acts as a vital professional link in the supply chain, facilitating market access through regulatory expertise. It is neither a factory (as it does not engage in mass production) nor a trading company (as it does not buy or sell inventory for profit), but rather a specialized service entity dedicated to legal and technical compliance.

Regulatory Affairs Department does not manufacture or sell products. It is an internal corporate division responsible for ensuring that a company complies with all of the regulations and laws pertaining to its business.

In Malaysia, such departments within pharmaceutical, medical device, or food companies are responsible for the following activities:

1. Submission of product registration applications to the National Pharmaceutical Regulatory Agency (NPRA).

2. Management of clinical trial authorizations.

3. Maintenance of product licenses and renewals.

4. Handling of post-market surveillance and adverse event reporting.

5. Ensuring compliance with the Drug Control Authority (DCA) and Ministry of Health (MOH) guidelines.

6. Managing labeling, packaging, and marketing material approvals to ensure they meet legal standards.

Therefore, the department acts as a liaison between the company and government health authorities rather than being a commercial entity that produces or sells goods.